// App-Quantinova.ai

2260 : Edoxaban Versus Enoxaparin for the Prevention of Venous Thromboembolism: Pooled Analysis of Coagulation Biomarkers From Stars E-3 and Stars J-V.

Researchers

Presenter

  • Satoru Fujita

Principal Investigators

  • Shintaro Tachibana

  • Yohko Kawai

Medical Centers

  • Department of Orthopaedic Surgery, Mishuku Hospital, Tokyo, Japan

  • Department of Orthopaedic Surgery, Takarazuka Daiichi Hospital, Takarazuka, Japan,

  • Preventive Health Examination Center, International University of Health and Welfare, Tokyo, Japan

  • Department of Surgery, Osaka Rosai Hospital, Sakai, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

  • Deep vein thrombosis

  • Pulmonary embolism

Biomarkers

  • D-dimer

  • Soluble fibrin monomer complex

Drug/Treatment

  • Enoxaparin

  • Enoxaparin sodium

  • Edoxaban

Outcome

  • N/A

Study Design

  • randomized

  • pharmacodynamics

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved